We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

21 hedge funds and large institutions have $3.45M invested in Alterity Therapeutics in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 1

596% more capital invested

Capital invested by funds: $496K → $3.45M (+$2.96M)

110% more funds holding

Funds holding: 10 → 21 (+11)

63% less call options, than puts

Call options by funds: $91K | Put options by funds: $245K

Holders
21
Holders Change
+11
Holders Change %
+110%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
6
Reduced
–
Closed
1
Calls
$91K
Puts
$245K
Net Calls
-$154K
Net Calls Change
-$154K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$624K
2
Morgan Stanley
Morgan Stanley
New York
+$612K
3
PA
Para Advisors
New York
+$191K
4
Federated Hermes
Federated Hermes
Pennsylvania
+$153K
5
Jane Street
Jane Street
New York
+$127K

Top Sellers

Rank Fund Capital Flow
1
ARTA
A.R.T. Advisors
New York
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$671K +$624K +2,720 New
Morgan Stanley
2
Morgan Stanley
New York
$657K +$612K +2,664 New
GBA
3
Garrison Bradford & Associates
New York
$414K +$57.4K +250 +17%
FC
4
FIC Capital
New York
$314K +$94.8K +413 +48%
AG
5
Aperio Group
California
$233K +$104K +452 +92%
PA
6
Para Advisors
New York
$206K +$191K +833 New
Federated Hermes
7
Federated Hermes
Pennsylvania
$164K +$153K +667 New
Jane Street
8
Jane Street
New York
$137K +$127K +555 New
Goldman Sachs
9
Goldman Sachs
New York
$127K +$118K +514 New
Bank of America
10
Bank of America
North Carolina
$123K +$80.3K +350 +233%
CS
11
Credit Suisse
Switzerland
$119K +$111K +483 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$69K +$64.3K +280 New
SB
13
Suntrust Banks
Georgia
$49K +$45.9K +200 New
VKH
14
Virtu KCG Holdings
New York
$48K +$44.8K +195 New
TRCT
15
Tower Research Capital (TRC)
New York
$47K +$25K +109 +135%
Group One Trading
16
Group One Trading
Illinois
$26K +$24.6K +107 New
Wells Fargo
17
Wells Fargo
California
$21K – – –
Ameriprise
18
Ameriprise
Minnesota
$10K – – –
Creative Planning
19
Creative Planning
Kansas
$10K +$7.8K +34 +425%
U
20
UBS
Switzerland
$8K +$7.58K +33 New
ARTA
21
A.R.T. Advisors
New York
– -$31K -223 Closed
Deutsche Bank
22
Deutsche Bank
Germany
– +$689 +3 New

ATHE Hedge Fund Activity: Q3 2013 in Review

21 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2013, worth a combined $3.45M — up 596% from $496K a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ATHE positions and 1 closed out — a net gain of 12 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $624K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $31K sold.

  • 21 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2013, up from 10 in Q2 2013.
  • Funds reported $3.45M of Alterity Therapeutics stock for Q3 2013, up 596% quarter-over-quarter.
  • 13 funds opened new Alterity Therapeutics positions in Q3 2013 and 1 closed out, a net change of +12 holders.
  • The largest Alterity Therapeutics buyer in Q3 2013 was Renaissance Technologies, an estimated $624K added.
  • The largest Alterity Therapeutics seller in Q3 2013 was A.R.T. Advisors, an estimated $31K sold.

Based on aggregated 13F filings for Q3 2013.